{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:30:12Z","timestamp":1790271012513,"version":"4.1.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01227","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T12:36:24Z","timestamp":1528115784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania"],"prefix":"10.3389","volume":"9","author":[{"given":"Negar","family":"Seyed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-7305-9_1","article-title":"Biology of human pathogenic trypanosomatids: epidemiology, lifecycle and ultrastructure","volume-title":"Proteins and Proteomics of Leishmania and Trypanosoma","author":"Rodrigues","year":"2014"},{"key":"B2","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"B3","first-page":"43","article-title":"Cutaneous lesions with very long duration as a complication of leishmanization","volume":"20","author":"Amini","year":"1991","journal-title":"Iran J Public Health"},{"key":"B4","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative review article","volume":"6","author":"Rezvan","year":"2015","journal-title":"Vet Res Forum"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral leishmaniasis: a review","volume":"422","author":"Jain","year":"2015","journal-title":"J Immunol Methods"},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1872208311666170510121126","article-title":"Recent advances in vaccines against Leishmania based on patent applications","volume":"12","author":"Thomaz-Soccol","year":"2018","journal-title":"Recent Pat Biotechnol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00005-008-0010-9","article-title":"Live attenuated Leishmania vaccines: a potential strategic alternative","volume":"56","author":"Silvestre","year":"2008","journal-title":"Arch Immunol Ther Exp"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1128\/IAI.72.6.3622-3627.2004","article-title":"Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies","volume":"72","author":"Spath","year":"2004","journal-title":"Infect Immun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/nar\/gkr834","article-title":"Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species","volume":"40","author":"Raymond","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fimmu.2014.00134","article-title":"Live vaccination tactics: possible approaches for controlling visceral leishmaniasis","volume":"5","author":"Saljoughian","year":"2014","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1038\/cti.2016.63","article-title":"A structure-function approach to optimizing TLR4 ligands for human vaccines","volume":"5","author":"Carter","year":"2016","journal-title":"Cli Transl Immunology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/eji.201444543","article-title":"Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-gamma","volume":"45","author":"Desbien","year":"2015","journal-title":"Eur J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/02652048.2014.958203","article-title":"Nanobiotechnologic approach to a promising vaccine prototype for immunisation against leishmaniasis: a fast and effective method to incorporate GPI-anchored proteins of Leishmania amazonensis into liposomes","volume":"32","author":"Colhone","year":"2015","journal-title":"J Microencapsul"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1016\/j.vaccine.2004.04.015","article-title":"Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniasis","volume":"22","author":"Iborra","year":"2004","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection","volume":"153","author":"Doroud","year":"2011","journal-title":"J Control Release"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1099\/jmm.0.029959-0","article-title":"Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB\/c mice","volume":"60","author":"Yam","year":"2011","journal-title":"J Med Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1016\/j.vaccine.2012.07.004","article-title":"Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB\/c mice against Leishmania major infection","volume":"30","author":"Hugentobler","year":"2012","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis","volume":"29","author":"Chakravarty","year":"2011","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1016\/j.vaccine.2010.08.092","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis","volume":"28","author":"Llanos-Cuentas","year":"2010","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2174","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0132794","DOI":"10.1371\/journal.pone.0132794","article-title":"Evaluation of live recombinant nonpathogenic Leishmania tarentolae expressing cysteine proteinase and A2 genes as a candidate vaccine against experimental canine visceral leishmaniasis","volume":"10","author":"Shahbazi","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis","volume":"18","author":"Goto","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.26719\/1997.3.2.284","article-title":"The experience of leishmanization in the Islamic Republic of Iran","volume":"3","author":"Nadim","year":"1997","journal-title":"East Mediterr Health J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of Leishmania abrogates vaccine-induced protective immunity","volume":"5","author":"Peters","year":"2009","journal-title":"PLoS Pathog"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/clinids\/13.5.1009","article-title":"Experimental leishmaniasis in humans: review","volume":"13","author":"Melby","year":"1991","journal-title":"Rev Infect Dis"},{"key":"B31","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"key":"B32","first-page":"306","article-title":"Problem and current lines in investigations on the epidemiology of leishmaniasis and its control in the U.S.S.R","volume":"74","author":"Kellina","year":"1981","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"B33","first-page":"240","article-title":"Characterization of Leishmania isolated from unhealed lesions caused by leishmanization","volume":"11","author":"Hosseini","year":"2005","journal-title":"East Mediterr Health J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4103\/0019-5154.94280","article-title":"Treatment of cutaneous lesion of 20 years\u2019 duration caused by leishmanization","volume":"57","author":"Khamesipour","year":"2012","journal-title":"Indian J Dermatol"},{"key":"B36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s40475-014-0024-9","article-title":"The emergence of defined subunit vaccines for the prevention of leishmaniasis","volume":"1","author":"Duthie","year":"2014","journal-title":"Curr Trop Med Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","article-title":"Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease","volume":"167","author":"Uzonna","year":"2001","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1108","article-title":"Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites","volume":"10","author":"Zaph","year":"2004","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.0105-2896.2004.00198.x","article-title":"The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development","volume":"201","author":"Scott","year":"2004","journal-title":"Immunol Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"E801","DOI":"10.1073\/pnas.1619265114","article-title":"Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts","volume":"114","author":"Mandell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/ni.2853","article-title":"Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem","volume":"15","author":"Sacks","year":"2014","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1002536","DOI":"10.1371\/journal.ppat.1002536","article-title":"Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response","volume":"8","author":"Ribeiro-Gomes","year":"2012","journal-title":"PLoS Pathog"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.1201676","article-title":"Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL\/6 mice","volume":"189","author":"Peters","year":"2012","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies","volume":"321","author":"Peters","year":"2008","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1128\/IAI.01600-13","article-title":"Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major","volume":"82","author":"Ribeiro-Gomes","year":"2014","journal-title":"Infect Immun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1004929","DOI":"10.1371\/journal.ppat.1004929","article-title":"Rapid sequestration of Leishmania mexicana by neutrophils contributes to the development of chronic lesion","volume":"11","author":"Hurrell","year":"2015","journal-title":"PLoS Pathog"},{"key":"B49","doi-asserted-by":"publisher","first-page":"6521","DOI":"10.4049\/jimmunol.173.11.6521","article-title":"Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages","volume":"173","author":"van Zandbergen","year":"2004","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1084\/jem.194.3.331","article-title":"Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein","volume":"194","author":"Valenzuela","year":"2001","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1000555","DOI":"10.1371\/journal.ppat.1000555","article-title":"Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival","volume":"5","author":"Rogers","year":"2009","journal-title":"PLoS Pathog"},{"key":"B52","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.celrep.2015.09.058","article-title":"Exosome secretion by the parasitic protozoan Leishmania within the sand fly midgut","volume":"13","author":"Atayde","year":"2015","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1126\/science.1199326","article-title":"Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis","volume":"331","author":"Ives","year":"2011","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1073\/pnas.1621447114","article-title":"Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis","volume":"114","author":"Rossi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.chom.2017.12.002","article-title":"Gut microbes egested during bites of infected sand flies augment severity of leishmaniasis via inflammasome-derived IL-1beta","volume":"23","author":"Dey","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B56","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1099\/00222615-32-3-189","article-title":"Effect of Leishmania major on human polymorphonuclear leucocyte function in vitro","volume":"32","author":"al Tuwaijri","year":"1990","journal-title":"J Med Microbiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1004538","DOI":"10.1371\/journal.ppat.1004538","article-title":"Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection","volume":"10","author":"Peters","year":"2014","journal-title":"PLoS Pathog"},{"key":"B60","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2011.08.016","article-title":"Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection","volume":"35","author":"Marshall","year":"2011","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.4049\/jimmunol.1500752","article-title":"Cutaneous infection with Leishmania major mediates heterologous protection against visceral infection with Leishmania infantum","volume":"195","author":"Romano","year":"2015","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20142101","article-title":"Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection","volume":"212","author":"Glennie","year":"2015","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.immuni.2007.01.017","article-title":"Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania","volume":"26","author":"Leon","year":"2007","journal-title":"Immunity"},{"key":"B64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coi.2003.11.007","article-title":"Activation of dendritic cells: translating innate into adaptive immunity","volume":"16","author":"e Sousa","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/978-1-4615-1971-3_114","article-title":"Dendritic cells seclude Leishmania parasites that persist in cured mice \u2013 a role in the maintenance of T-cell memory?","volume":"378","author":"Moll","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/eji.1830250310","article-title":"Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response","volume":"25","author":"Moll","year":"1995","journal-title":"Eur J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/pim.12360","article-title":"Overview of dendritic cell-based vaccine development for leishmaniasis","volume":"38","author":"Bagirova","year":"2016","journal-title":"Parasite Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e48727","DOI":"10.1371\/journal.pone.0048727","article-title":"CXCL10 is critical for the generation of protective CD8 T cell response induced by antigen pulsed CpG-ODN activated dendritic cells","volume":"7","author":"Majumder","year":"2012","journal-title":"PLoS One"},{"key":"B69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2014.00261","article-title":"Antigen-pulsed CpG-ODN-activated dendritic cells induce host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice: critical role of CXCL10","volume":"5","author":"Majumder","year":"2014","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"ftw041","DOI":"10.1093\/femspd\/ftw041","article-title":"SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCbeta","volume":"74","author":"Jawed","year":"2016","journal-title":"Pathog Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3800::AID-IMMU3800>3.0.CO;2-0","article-title":"Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major","volume":"28","author":"Flohe","year":"1998","journal-title":"Eur J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1016\/j.vaccine.2010.06.077","article-title":"Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major","volume":"28","author":"Schnitzer","year":"2010","journal-title":"Vaccine"},{"key":"B73","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.4049\/jimmunol.172.10.6281","article-title":"Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC","volume":"172","author":"Ramirez-Pineda","year":"2004","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1003476","DOI":"10.1371\/journal.ppat.1003476","article-title":"T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine","volume":"9","author":"Schwarz","year":"2013","journal-title":"PLoS Pathog"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2217\/imt.14.102","article-title":"Leishmania infantum FML pulsed-dendritic cells induce a protective immune response in murine visceral leishmaniasis","volume":"7","author":"Foroughi-Parvar","year":"2015","journal-title":"Immunotherapy"},{"key":"B76","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1016\/j.vaccine.2012.05.075","article-title":"Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis","volume":"30","author":"Agallou","year":"2012","journal-title":"Vaccine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.4049\/jimmunol.170.6.3171","article-title":"Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens","volume":"170","author":"Berberich","year":"2003","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1002\/1521-4141(2000012)30:12<3498::AID-IMMU3498>3.0.CO;2-6","article-title":"Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis","volume":"30","author":"von Stebut","year":"2000","journal-title":"Eur J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e67453","DOI":"10.1371\/journal.pone.0067453","article-title":"Targeting Leishmania major antigens to dendritic cells in vivo induces protective immunity","volume":"8","author":"Matos","year":"2013","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cimid.2017.07.002","article-title":"Alternative strategy for visceral leishmaniosis control: HisAK70-salmonella choleraesuis-pulsed dendritic cells","volume":"54","author":"Dom\u00ednguez-Bernal","year":"2017","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e00108-17","DOI":"10.1128\/CVI.00108-17","article-title":"Not all antigens are created equally: progress, challenges and lessons associated with developing a vaccine for leishmaniasis","volume":"24","author":"Duthie","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri3689","article-title":"Follicular dendritic cells: dynamic antigen libraries","volume":"14","author":"Heesters","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1600-065X.1980.tb01039.x","article-title":"The follicular dendritic cell: long term antigen retention during immunity","volume":"53","author":"Mandel","year":"1980","journal-title":"Immunol Rev"},{"key":"B84","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/eji.201444651","article-title":"Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice","volume":"45","author":"Martinez-Lopez","year":"2015","journal-title":"Eur J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1087499","article-title":"Persistence without pathology in phosphoglycan-deficient Leishmania major","volume":"301","author":"Spath","year":"2003","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fimmu.2014.00213","article-title":"Genetically modified organisms and visceral leishmaniasis","volume":"5","author":"Chhajer","year":"2014","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Gon\u00e7alo do Amaranto, RN)","volume":"19","author":"da Silva","year":"2001","journal-title":"Vaccine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"B91","first-page":"179","article-title":"N-linked oligosaccharide structures of the FML antigen of Leishmania donovani","volume":"93","author":"Bernardo","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B92","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.4049\/jimmunol.136.12.4681","article-title":"Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism","volume":"136","author":"Wilson","year":"1986","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.vetpar.2016.07.011","article-title":"Current status on prevention and treatment of canine leishmaniasis","volume":"227","author":"Reguera","year":"2016","journal-title":"Vet Parasitol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","article-title":"Canine Leishmania vaccines: still a long way to go","volume":"208","author":"Gradoni","year":"2015","journal-title":"Vet Parasitol"},{"key":"B95","first-page":"13","article-title":"Field randomized double-blind trial to evaluate the efficacy of a vaccine against canine visceral leishmaniasis in Porteirinha municipality, South-Eastern Brazil","volume":"5","author":"Tib\u00farcio","year":"2013","journal-title":"World Leish"},{"key":"B96","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.vetpar.2014.04.025","article-title":"Antibody responses induced by Leish-Tec(R), an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population","volume":"204","author":"Testasicca","year":"2014","journal-title":"Vet Parasitol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T23:41:46Z","timestamp":1693698106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":96,"alternative-id":["10.3389\/fimmu.2018.01227"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01227","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"article-number":"1227"}}